Sall4 is A Key Factor in Hdac Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor Cd34+Cd90+Cells
Hiro Tatetsu,Fei Wang,Chong Gao,Shikiko Ueno,Xi Tian,Myriam Armant,Alex Federation,Jun Qi,James E. Bradner,Daniel G. Tenen,Li Chai
DOI: https://doi.org/10.1182/blood.v124.21.1566.1566
IF: 20.3
2014-01-01
Blood
Abstract:Hematopoietic stem cells (HSCs) possess the unique capacity to self-renew and give rise to all types of mature cells within the blood and immune systems. Despite our progress in understanding the molecular factors that support the self-renewal and differentiation of the hematopoietic system in vivo, less is known on how to modulate the factors that govern the self-renewal of hematopoietic stem/progenitor cells (HSPCs) ex vivo. Unlike in the case of embryonic stem (ES) cells, expansion of CD34+ HSPC in culture in general is at the expense of loss of “stemness”.
What problem does this paper attempt to address?